Qiagen gets $598K to make syndromic COVID-19 test

LabPulse.com staff writers
Mar 12, 2020
2019 04 26 21 48 5250 Money Hundred Bills 400

The U.S. Department of Health and Human Services (HHS) will contribute $598,000 to Qiagen to develop a test kit to detect the genetic material of SARS-CoV-2, the virus that causes the COVID-19 novel coronavirus disease.

Qiagen's QIAstat-Dx respiratory SARS-CoV-2 panel test kit will differentiate SARS-CoV-2 from 21 other bacterial and viral pathogens implicated in respiratory syndromes in about an hour. Its test will include assays targeting two genes used to detect SARS-CoV-2.

The panel is the first syndromic test selected and funded by HHS' Biomedical Advanced Research and Development Authority (BARDA) to help accelerate the response to COVID-19, the company stated.

Latest in COVID-19
Doctor Nurse Mask Icu Social
Report: Lack of standardization a ‘huge’ issue during pandemic, problems persist
September 15, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Covid Brain Visual Social
Study: Blood clotting proteins may contribute to COVID-19 'brain fog,' cognitive problems
September 13, 2023
Nasal Swab Test Social
Researchers create low-cost, eco-friendly COVID-19 test
September 12, 2023
Related Stories
Financials Growth Revenue Business Social
Financial Results
As Qiagen Q4 net sales declined 14%, base business sales grew double digits
2020 03 31 18 05 5944 2020 03 31 Qiagen Qi Astat Covid 19 20200331181326
COVID-19
Qiagen gets FDA nod for syndromic SARS-CoV-2 test
2020 03 25 23 07 4711 Bernard Thierry 400 Thumb
Molecular Diagnostics
Qiagen taps CEO, ships coronavirus tests to U.S.
At-home or Lab-based STI testing/collection
Sponsor Content
At-home or Lab-based STI testing/collection
More in COVID-19
Report: Lack of standardization a ‘huge’ issue during pandemic, problems persist
A lack of standardization of infectious disease consumables was “a huge, unanticipated issue during the pandemic” that still needs to be resolved, according to a report in GenomeWeb.
September 15, 2023
Doctor Nurse Mask Icu Social
Whistleblower claims CIA analysts were bribed to reject COVID-19 'lab leak' origin hypothesis
A whistleblower gave testimony to two panels of the House of Representatives alleging that six CIA analysts were bribed to reject the theory that the COVID-19 pandemic resulted from a research-related leak of a new coronavirus.
September 15, 2023
Infectious Diseases Research Social
Study: Blood clotting proteins may contribute to COVID-19 'brain fog,' cognitive problems
The presence of blood clots may help explain cognitive problems such as "brain fog" in patients following COVID-19 infection, say researchers.
September 13, 2023
Covid Brain Visual Social
Researchers create low-cost, eco-friendly COVID-19 test
Scientists say they have engineered an accurate, low-cost, and eco-friendly COVID-19 test that could dramatically reduce environmental waste.
September 12, 2023
Nasal Swab Test Social
NIH study shows value of repeat use of COVID-19 antigen tests
Researchers have published the performance data that prompted the U.S. Food and Drug Administration to revise its position on COVID-19 testing last year.
September 11, 2023
Covid Diagnostic Test Kit Social
Single-cell sequencing shows population-level drivers of COVID-19 responses
To assess population-level variation, the researchers performed single-cell RNA sequencing on peripheral blood mononuclear cells taken from 222 healthy donors of diverse ancestries.
August 15, 2023
Covid Virus Dna Molecule Social
Viral vector-based decoy receptors protect mice against COVID-19 infection
Rather than target the viral protein, the researchers proposed introducing a decoy version of the ACE2 protein that SARS-CoV-2 binds to when entering cells.
August 2, 2023
Coronavirus Receptor Viralentry Social
OIG audit shows some IHS COVID-19 funds misused, recommendations issued
The OIG determined that the funds were misused – or not used before the funds expired – because the IHS did not provide clear guidance or oversight to the programs for the use of the funds or the accounting and tracking of these funds.
August 2, 2023
Dollar Money Coronavirus Mask Social
FDA awards EUA to Alphadera Labs’ COVID-19 test
Alphadera Labs received the EUA after evaluating its test on 60 clinical nasopharyngeal swabs specimens. ALPHADx provided the same results as a “highly sensitive” FDA-authorized molecular SARS-CoV-2 test.
August 2, 2023
Coronavirus Covid Blue Social
Co-Diagnostics penalized by SEC for COVID-19 test claims, failing to disclose hiring of relatives
The SEC has filed a cease-and-desist order and fined Co-Diagnostics $250,000 due to allegations that the firm filed misleading press releases about its COVID-19 tests and not disclosing financial transactions involving the family members of executives.
July 10, 2023
Gavel Money Social
FDA authorizes Discover Labs to run molecular COVID-19 test at its Texas facility
Under the terms of the EUA, Discover Labs can run the COVID-19 test at its CLIA-certified Austin facility. The test is for prescription use only.
July 7, 2023
Fda Button Social
Georgia urgent care chain to pay $1.6M to resolve lawsuits involving COVID-19 testing, treatment
This civil settlement resolves lawsuits filed in the U.S. District Court for the Northern District of Georgia by former employees of CRH Healthcare under whistleblower provisions of the False Claims Act.
June 22, 2023
Gavel Legal Business Social
Page 1 of 33
Next Page